{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:13:09Z","timestamp":1759191189033,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u00c7anakkale Onsekiz Mart University , The Scientific Research Coordination Unit","award":["THD-2022-3867"],"award-info":[{"award-number":["THD-2022-3867"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14866-4","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:36:45Z","timestamp":1759160205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the cytotoxicity and genotoxicity of Vortioxetine with in vivo and in silico methods"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-9717","authenticated-orcid":false,"given":"Meliha Merve","family":"\u00c7icekliyurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-1458","authenticated-orcid":false,"given":"P\u0131nar","family":"\u0130nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0336-3010","authenticated-orcid":false,"given":"Melih","family":"G\u00fcnay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4482-7352","authenticated-orcid":false,"given":"G\u00fcls\u00fcm","family":"Akku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altu\u011f","family":"\u00c7i\u00e7ekliyurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"14866_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5114\/fn.2021.108550","volume":"59","author":"AN Xu","year":"2021","unstructured":"Xu, A. N. & Nie, F. Brain-derived neurotrophic factor enhances the therapeutic effect of Oleuropein in the lipopolysaccharide-induced models of depression. Folia Neuropathol. 59, 249\u2013262 (2021).","journal-title":"Folia Neuropathol."},{"key":"14866_CR2","unstructured":"Falk, A., Joseph, R., Smith, S. & Wilk, A. Major Depressive Disorder. | EBSCOhost. 7 (2023). https:\/\/openurl.ebsco.com\/contentitem\/gcd:163177980?sid=ebsco:plink:crawler&id=ebsco:gcd:163177980"},{"key":"14866_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jama.2023.2428","volume":"329","author":"F Leichsenring","year":"2023","unstructured":"Leichsenring, F., Heim, N. & Steinert, C. A review of anxiety disorders. JAMA 329, 1315\u20131316 (2023).","journal-title":"JAMA"},{"key":"14866_CR4","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1007\/s12035-022-02780-z","volume":"59","author":"NJ Khushboo, Siddiqi","year":"2022","unstructured":"Khushboo, Siddiqi, N. J., de Lourdes Pereira, M., Sharma, B. & Neuroanatomical Biochemical, and functional modifications in brain induced by treatment with antidepressants. Mol. Neurobiol. 59, 3564\u20133584 (2022).","journal-title":"Mol. Neurobiol."},{"key":"14866_CR5","first-page":"36","volume":"40","author":"A D\u2019Agostino","year":"2015","unstructured":"D\u2019Agostino, A., English, C. D. & Rey, J. A. Vortioxetine (Brintellix): A new serotonergic antidepressant. Pharm. Ther. 40, 36\u201340 (2015).","journal-title":"Pharm. Ther."},{"key":"14866_CR6","doi-asserted-by":"crossref","unstructured":"David, D. J. et al. Propri\u00e9t\u00e9s pharmacologiques de La Vortioxetine et leurs cons\u00e9quences pr\u00e9-cliniques. L\u2019Enc\u00e9phale 42, (1 Suppl 1) 1S12\u20131S23 (2016).","DOI":"10.1016\/S0013-7006(16)30015-X"},{"key":"14866_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/14740338.2022.2019705","volume":"21","author":"J De Diego-Adeli\u00f1o","year":"2022","unstructured":"De Diego-Adeli\u00f1o, J. et al. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opin. Drug Saf. 21, 673\u2013690 (2022).","journal-title":"Expert Opin. Drug Saf."},{"key":"14866_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0027-5107(93)90049-L","volume":"285","author":"M Fenech","year":"1993","unstructured":"Fenech, M. The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res. Mol. Mech. Mutagen. 285, 35\u201344 (1993).","journal-title":"Mutat. Res. Mol. Mech. Mutagen."},{"key":"14866_CR9","doi-asserted-by":"publisher","first-page":"132341","DOI":"10.1016\/j.molstruc.2022.132341","volume":"1254","author":"A Husain","year":"2022","unstructured":"Husain, A. & ACh, P. DNA binding affinities, anti-oxidant, antimicrobial and molecular Docking activities of Pd (II) complexes of Chromone schiff bases. J. Mol. Struct. 1254, 132341 (2022).","journal-title":"J. Mol. Struct."},{"key":"14866_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/01480545.2017.1365885","volume":"41","author":"H Cobanoglu","year":"2018","unstructured":"Cobanoglu, H., Coskun, M., \u00c7ayir, A. & Coskun, M. In vitro genotoxic and cytotoxic effects of Doxepin and Escitalopram on human peripheral lymphocytes. Drug Chem. Toxicol. 41, 238\u2013244 (2018).","journal-title":"Drug Chem. Toxicol."},{"key":"14866_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/01480545.2016.1174870","volume":"40","author":"E Avuloglu Yilmaz","year":"2017","unstructured":"Avuloglu Yilmaz, E., Unal, F. & Yuzbasioglu, D. Evaluation of cytogenetic and DNA damage induced by the antidepressant drug-active ingredients, Trazodone and milnacipran, in vitro. Drug Chem. Toxicol. 40, 57\u201366 (2017).","journal-title":"Drug Chem. Toxicol."},{"key":"14866_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/01480545.2018.1486410","volume":"43","author":"S Ayabakt\u0131","year":"2020","unstructured":"Ayabakt\u0131, S. & Yavuz Kocaman, A. Cytogenotoxic effects of Venlafaxine hydrochloride on cultured human peripheral blood lymphocytes. Drug Chem. Toxicol. 43, 192\u2013199 (2020).","journal-title":"Drug Chem. Toxicol."},{"key":"14866_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/0891-5849(94)00209-3","volume":"18","author":"AP Breen","year":"1995","unstructured":"Breen, A. P. & Murphy, J. A. Reactions of oxyl radicals with DNA. Free Radic Biol. Med. 18, 1033\u20131077 (1995).","journal-title":"Free Radic Biol. Med."},{"key":"14866_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2116\/analsci.24.1437","volume":"24","author":"A Shah","year":"2008","unstructured":"Shah, A., Qureshi, R., Janjua, N. K., Haque, S. & Ahmad, S. Electrochemical and spectroscopic investigations of protonated ferrocene-DNA intercalation. Anal. Sci. Int. J. Jpn Soc. Anal. Chem. 24, 1437\u20131441 (2008).","journal-title":"Anal. Sci. Int. J. Jpn Soc. Anal. Chem."},{"key":"14866_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.30574\/gscbps.2024.29.2.0408","volume":"29","author":"P \u0130nan","year":"2024","unstructured":"\u0130nan, P. & G\u00fcle\u00e7, N. Investigation of biological activities of 2-{(E)-[(pyridin-3-yl)imino]methyl}phenol schiff base. GSC Biol. Pharm. Sci. 29, 104\u2013113 (2024).","journal-title":"GSC Biol. Pharm. Sci."},{"key":"14866_CR16","doi-asserted-by":"publisher","first-page":"130539","DOI":"10.1016\/j.molstruc.2021.130539","volume":"1239","author":"S Kecel-Gunduz","year":"2021","unstructured":"Kecel-Gunduz, S. et al. Computer-aided anticancer drug design: In vitro and in Silico studies of new iminocoumarin derivative. J. Mol. Struct. 1239, 130539 (2021).","journal-title":"J. Mol. Struct."},{"key":"14866_CR17","first-page":"7","volume":"11","author":"LP da Silva","year":"2018","unstructured":"da Silva, L. P., Marinho, E. M. & Marinho, M. M. In Silico study of antidepressant drug vortioxetine: A description of their physical chemistry properties using classical molecular mechanics methods MMFF94. Int. J. Recent. Res. Rev. 11, 7\u201313 (2018).","journal-title":"Int. J. Recent. Res. Rev."},{"key":"14866_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molstruc.2017.05.022","volume":"1144","author":"S Daravath","year":"2017","unstructured":"Daravath, S. et al. Design, synthesis, spectral characterization, DNA interaction and biological activity studies of copper(II), cobalt(II) and nickel(II) complexes of 6-amino benzothiazole derivatives. J. Mol. Struct. 1144, 147\u2013158 (2017).","journal-title":"J. Mol. Struct."},{"key":"14866_CR19","doi-asserted-by":"crossref","unstructured":"Evans, H. J. Human Peripheral Blood Lymphocytes for the Analysis of Chromosome Aberrations in Mutagen Tests (Elsevier Science Pub Co Inc, 1984).","DOI":"10.1016\/B978-0-444-80519-5.50023-7"},{"key":"14866_CR20","doi-asserted-by":"publisher","unstructured":"Perry, P. E. & Thomson, E. J. Elsevier, Amsterdam,. The methodology of sister chromatid exchanges. in Handbook of Mutagenicity Test Procedures (Second Edition) (eds. Kilbey, B. J., Legator, M., Nichols, W. & Ramel, C.) 495\u2013529 (1984). https:\/\/doi.org\/10.1016\/B978-0-444-80519-5.50029-8","DOI":"10.1016\/B978-0-444-80519-5.50029-8"},{"key":"14866_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0022-2836(61)80047-8","volume":"3","author":"J Marmur","year":"1961","unstructured":"Marmur, J. A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J. Mol. Biol. 3, 208\u2013IN1 (1961).","journal-title":"J. Mol. Biol."},{"key":"14866_CR22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jinorgbio.2007.12.033","volume":"102","author":"VC da Silveira","year":"2008","unstructured":"da Silveira, V. C. et al. Double-strand DNA cleavage induced by oxindole-Schiff base copper(II) complexes with potential antitumor activity. J. Inorg. Biochem. 102, 1090\u20131103 (2008).","journal-title":"J. Inorg. Biochem."},{"key":"14866_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1107\/S0907444994010759","volume":"51","author":"K Balendiran","year":"1995","unstructured":"Balendiran, K., Rao, S. T., Sekharudu, C. Y., Zon, G. & Sundaralingam, M. X-ray structures of the B-DNA Dodecamer d(CGCGTTAACGCG) with an inverted central tetranucleotide and its Netropsin complex. Acta Crystallogr. D Biol. Crystallogr. 51, 190\u2013198 (1995).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14866-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14866-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:36:48Z","timestamp":1759160208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14866-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14866"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14866-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33647"}}